BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) traded up 0.8% on Tuesday . The stock traded as high as $7.97 and last traded at $7.97. 761 shares were traded during mid-day trading, a decline of 73% from the average session volume of 2,861 shares. The stock had previously closed at $7.90.
BioSyent Trading Up 0.8 %
The business has a 50-day moving average price of $7.63 and a two-hundred day moving average price of $7.81.
BioSyent Increases Dividend
The company also recently disclosed a dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.0347 per share. This represents a yield of 1.77%. This is an increase from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Friday, February 28th.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Read More
- Five stocks we like better than BioSyent
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Trading Stocks: RSI and Why it’s Useful
- The Top-Ranked Insider Buys From April by Market Cap
- Basic Materials Stocks Investing
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
